Bioliberty's Lifehub Clinic rehabilitation technology featuring the Lifeglov soft robotic glove for hand and upper-limb therapy.
Bioliberty has secured a $3.3 million Series A extension backed by four investors. The Edinburgh-based rehabilitation technology company plans to expand its US operations, engineering team and hardware manufacturing capabilities.

Bioliberty, an Edinburgh, UK-based healthtech company developing robotic rehabilitation technology, has secured an additional $3.3 million in Series A financing. The extension attracted investments from TGH Ventures, Ballad Ventures, 25M Health and Northern Ireland-based Whiterock.

The investment follows Bioliberty’s earlier financing announcement in March 2026, which included an $8.2 million Series A led by a $4 million commitment from the Scottish National Investment Bank. Other investors in that round included Archangels, Eos Advisory, Old College Capital, Hanna Capital SEZC and Conduit Connect. The March announcement also included $2 million in pre-Series A financing completed in 2025. Together with the latest extension, these financings amount to $13.5 million.

Founded in 2020 by Rowan Armstrong, Ross O’Hanlon, Shéa Quinn and Conan Bradley, Bioliberty develops rehabilitation devices and software for people recovering from strokes and other neurological conditions. Armstrong serves as chief executive officer, while O’Hanlon leads technology development, Bradley oversees commercial operations and Quinn manages company operations.

The company’s Lifehub Clinic platform combines its Lifeglov soft robotic glove with interactive rehabilitation software. The system assists patients with repetitive hand movements through game-based therapy activities, while capturing treatment data that clinicians can use to monitor progress and adjust rehabilitation programmes. Its Lifemind interface also provides therapy records and AI-generated session notes.

Bioliberty plans to deploy the new capital towards expanding its commercial operations in the United States, increasing engineering and customer success capacity, and developing its hardware manufacturing capabilities. The company has already introduced Lifehub Clinic at US rehabilitation facilities, including Sheltering Arms Institute, and has collaborated with Mount Sinai on rehabilitation research.

Bioliberty launched Lifehub Clinic in 2025 and maintains operations in Edinburgh and the Boston area. Its ongoing development work includes extending rehabilitation support into patients’ homes and expanding the use of AI-based functional assessments to help clinicians evaluate recovery.

Get the latest startup funding news in your inbox.

We don’t spam! Read our privacy policy for more info.

Share